Olivier Waridel, previously CEO of medical device company Biosafe and now GM of Cell Banking & Point of Care at GE Healthcare, describes automating cell processing and the benefit of partnerships in cell therapy.

Waridel was interviewed at Cell Therapy Manufacturing & Gene Therapy Congress - find at more at [ Ссылка ].

свернуть